Adage Capital Partners’s aTyr Pharma ATYR Stock Holding History
Bought
Maintained
Sold
Other funds holding ATYR
TM
Adage Capital Partners's ATYR Position: Q1 2025 in Review
Adage Capital Partners sold out of aTyr Pharma (ATYR) in Q1 2025, closing a stake of 25,000 shares — an estimated $3.62M sold.
Adage Capital Partners first reported a position in ATYR in Q2 2024 and held it in 3 quarters. The position peaked at $3.62M in Q4 2024. 85 funds tracked by Wall St. Rank hold ATYR as of Q1 2025.
- Adage Capital Partners reported no remaining aTyr Pharma position as of Q1 2025 after selling out during the quarter.
- Adage Capital Partners sold 25,000 aTyr Pharma shares in Q1 2025, an estimated $3.62M.
- Adage Capital Partners first reported a position in aTyr Pharma in Q2 2024 and held it in 3 quarters.
- Adage Capital Partners's aTyr Pharma position peaked at $3.62M in Q4 2024.
- 85 funds tracked by Wall St. Rank held aTyr Pharma as of Q1 2025.
Based on Adage Capital Partners's 13F filing for Q1 2025, filed 15 May 2025.